Regina M. Botting
- Pharmacology top 0.2%
- Physiology top 1%
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 2%
- Biochemistry top 0.5%
- Co-authors
- John R. VaneDaniel L. SimmonsTimothy HlaErik ÄnggårdFranklin H. EpsteinSamir S. AyoubTomasz A. SwierkoszJane A. Mitchell
- Topics
- Inflammatory mediators and NSAID effects (19 papers)Eicosanoids and Hypertension Pharmacology (8 papers)Pain Mechanisms and Treatments (6 papers)
- Cited by
- PharmacologyBiochemistryPhysiology
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesClinical Infectious Diseases
- Partner nations
- United KingdomUnited States
In The Last Decade
Regina M. Botting
29 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Pharmacology 1.9k
- Physiology 1.4k
- Molecular Biology 996
- Cardiology and Cardiovascular Medicine 953
- Biochemistry 756
Countries citing papers authored by Regina M. Botting
This map shows the geographic impact of Regina M. Botting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regina M. Botting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regina M. Botting more than expected).
Fields of papers citing papers by Regina M. Botting
This network shows the impact of papers produced by Regina M. Botting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regina M. Botting. The network helps show where Regina M. Botting may publish in the future.
Co-authorship network of co-authors of Regina M. Botting
This figure shows the co-authorship network connecting the top 25 collaborators of Regina M. Botting. A scholar is included among the top collaborators of Regina M. Botting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regina M. Botting. Regina M. Botting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 82 | |
| 2 | 5 | |
| 3 | 61 | |
| 4 | 17 | |
| 5 | 120 | |
| 6 | Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibitionbreakdown → | 1363 |
| 7 | 56 | |
| 8 | 266 | |
| 9 | 12 | |
| 10 | Improved non-steroid anti-inflammatory drugs COX-2 enzyme inhibitors : proceedings of a conference held on October 10-11, 1995, at Regent's College, London | 3 |
| 11 | 48 | |
| 12 | 226 | |
| 13 | 300 | |
| 14 | 67 | |
| 15 | Aspirin and Other Salicylates | 82 |
| 16 | Regulatory Functions of the Vascular Endotheliumbreakdown → | 1533 |
| 17 | Inflammation and the mechanism of action of anti‐inflammatory drugsbreakdown → | 439 |
| 18 | 11 | |
| 19 | 10 | |
| 20 | 13 |
About Regina M. Botting
Regina M. Botting is a scholar working on Pharmacology, Biochemistry and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 5.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (19 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Pain Mechanisms and Treatments (6 papers). The work is most often cited by research in Pharmacology (1.9k citations), Biochemistry (756 citations) and Physiology (1.4k citations). Regina M. Botting has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include John R. Vane, Daniel L. Simmons, Timothy Hla, Erik Änggård, Franklin H. Epstein, Samir S. Ayoub, Tomasz A. Swierkosz, Jane A. Mitchell, Timothy D. Warner and Leslie R. Ballou. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.